Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy

Clinical trial NCT00966836 · UNKNOWN

Trial details

NCT number: NCT00966836
Sponsor: University of Bologna
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Heart Transplantation Cardiac Allograft Vasculopathy Cytomegalovirus Infection

Start date: 2009-04-01
Primary completion: 2012-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.